Atlas Trials

An Open Label Study of Oral Enzastaurin in Participants With Cancer

Clinical trial NCT00309140 · COMPLETED

Trial details

NCT number
NCT00309140
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
NeoplasmsCancer
Start date
2006-03-01
Primary completion
2009-07-01
Enrollment
23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.